Home > Research > Publications & Outputs > Accuracy and applications of sequencing and gen...

Electronic data

  • submission_AL

    Accepted author manuscript, 4.43 MB, PDF document

    Available under license: CC BY-NC: Creative Commons Attribution-NonCommercial 4.0 International License

Links

Text available via DOI:

View graph of relations

Accuracy and applications of sequencing and genotyping approaches for CYP2A6 and homologous genes

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

Accuracy and applications of sequencing and genotyping approaches for CYP2A6 and homologous genes. / Langlois, Alec W R; El-Boraie, Ahmed; Fukunaga, Koya et al.
In: Pharmacogenetics and genomics, Vol. 32, No. 4, 30.06.2022, p. 159-172.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

Langlois, AWR, El-Boraie, A, Fukunaga, K, Mushiroda, T, Kubo, M, Lerman, C, Knight, J, Scherer, SE, Chenoweth, MJ & Tyndale, RF 2022, 'Accuracy and applications of sequencing and genotyping approaches for CYP2A6 and homologous genes', Pharmacogenetics and genomics, vol. 32, no. 4, pp. 159-172. https://doi.org/10.1097/FPC.0000000000000466

APA

Langlois, A. W. R., El-Boraie, A., Fukunaga, K., Mushiroda, T., Kubo, M., Lerman, C., Knight, J., Scherer, S. E., Chenoweth, M. J., & Tyndale, R. F. (2022). Accuracy and applications of sequencing and genotyping approaches for CYP2A6 and homologous genes. Pharmacogenetics and genomics, 32(4), 159-172. https://doi.org/10.1097/FPC.0000000000000466

Vancouver

Langlois AWR, El-Boraie A, Fukunaga K, Mushiroda T, Kubo M, Lerman C et al. Accuracy and applications of sequencing and genotyping approaches for CYP2A6 and homologous genes. Pharmacogenetics and genomics. 2022 Jun 30;32(4):159-172. Epub 2022 Feb 21. doi: 10.1097/FPC.0000000000000466

Author

Langlois, Alec W R ; El-Boraie, Ahmed ; Fukunaga, Koya et al. / Accuracy and applications of sequencing and genotyping approaches for CYP2A6 and homologous genes. In: Pharmacogenetics and genomics. 2022 ; Vol. 32, No. 4. pp. 159-172.

Bibtex

@article{2c389d8fb51149cc8ede6262fdf331d0,
title = "Accuracy and applications of sequencing and genotyping approaches for CYP2A6 and homologous genes",
abstract = "We evaluated multiple genotyping/sequencing approaches in a homologous region of chromosome 19, and investigated associations of two common 3'-UTR CYP2A6 variants with activity in vivo. Individuals (n = 1704) of European and African ancestry were phenotyped for the nicotine metabolite ratio (NMR), an index of CYP2A6 activity, and genotyped/sequenced using deep amplicon exon sequencing, SNP array, genotype imputation and targeted capture sequencing. Amplicon exon sequencing was the gold standard to which other methods were compared within-individual for CYP2A6, CYP2A7, CYP2A13, and CYP2B6 exons to identify highly discordant positions. Linear regression models evaluated the association of CYP2A6*1B and rs8192733 genotypes (coded additively) with logNMR. All approaches were ≤2.6% discordant with the gold standard; discordant calls were concentrated at few positions. Fifteen positions were discordant in >10% of individuals, with 12 appearing in regions of high identity between homologous genes (e.g. CYP2A6 and CYP2A7). For six, allele frequencies in our study and online databases were discrepant, suggesting errors in online sources. In the European-ancestry group (n = 935), CYP2A6*1B and rs8192733 were associated with logNMR (P <0.001). A combined model found main effects of both variants on increasing logNMR. Similar trends were found in those of African ancestry (n = 506). Multiple genotyping/sequencing approaches used in this chromosome 19 region contain genotyping/sequencing errors, as do online databases. Gene-specific primers and SNP array probes must consider gene homology; short-read sequencing of related genes in a single reaction should be avoided. Using improved sequencing approaches, we characterized two gain-of-function 3'-UTR variants, including the relatively understudied rs8192733. [Abstract copyright: Copyright {\textcopyright} 2022 Wolters Kluwer Health, Inc. All rights reserved.]",
keywords = "3′-UTR, CYP2A6, nicotine metabolite ratio, pharmacogenetics, sequencing, smoking",
author = "Langlois, {Alec W R} and Ahmed El-Boraie and Koya Fukunaga and Taisei Mushiroda and Michiaki Kubo and Caryn Lerman and Jo Knight and Scherer, {Steven E} and Chenoweth, {Meghan J} and Tyndale, {Rachel F}",
year = "2022",
month = jun,
day = "30",
doi = "10.1097/FPC.0000000000000466",
language = "English",
volume = "32",
pages = "159--172",
journal = "Pharmacogenetics and genomics",
issn = "1744-6880",
publisher = "Lippincott Williams and Wilkins Ltd.",
number = "4",

}

RIS

TY - JOUR

T1 - Accuracy and applications of sequencing and genotyping approaches for CYP2A6 and homologous genes

AU - Langlois, Alec W R

AU - El-Boraie, Ahmed

AU - Fukunaga, Koya

AU - Mushiroda, Taisei

AU - Kubo, Michiaki

AU - Lerman, Caryn

AU - Knight, Jo

AU - Scherer, Steven E

AU - Chenoweth, Meghan J

AU - Tyndale, Rachel F

PY - 2022/6/30

Y1 - 2022/6/30

N2 - We evaluated multiple genotyping/sequencing approaches in a homologous region of chromosome 19, and investigated associations of two common 3'-UTR CYP2A6 variants with activity in vivo. Individuals (n = 1704) of European and African ancestry were phenotyped for the nicotine metabolite ratio (NMR), an index of CYP2A6 activity, and genotyped/sequenced using deep amplicon exon sequencing, SNP array, genotype imputation and targeted capture sequencing. Amplicon exon sequencing was the gold standard to which other methods were compared within-individual for CYP2A6, CYP2A7, CYP2A13, and CYP2B6 exons to identify highly discordant positions. Linear regression models evaluated the association of CYP2A6*1B and rs8192733 genotypes (coded additively) with logNMR. All approaches were ≤2.6% discordant with the gold standard; discordant calls were concentrated at few positions. Fifteen positions were discordant in >10% of individuals, with 12 appearing in regions of high identity between homologous genes (e.g. CYP2A6 and CYP2A7). For six, allele frequencies in our study and online databases were discrepant, suggesting errors in online sources. In the European-ancestry group (n = 935), CYP2A6*1B and rs8192733 were associated with logNMR (P <0.001). A combined model found main effects of both variants on increasing logNMR. Similar trends were found in those of African ancestry (n = 506). Multiple genotyping/sequencing approaches used in this chromosome 19 region contain genotyping/sequencing errors, as do online databases. Gene-specific primers and SNP array probes must consider gene homology; short-read sequencing of related genes in a single reaction should be avoided. Using improved sequencing approaches, we characterized two gain-of-function 3'-UTR variants, including the relatively understudied rs8192733. [Abstract copyright: Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.]

AB - We evaluated multiple genotyping/sequencing approaches in a homologous region of chromosome 19, and investigated associations of two common 3'-UTR CYP2A6 variants with activity in vivo. Individuals (n = 1704) of European and African ancestry were phenotyped for the nicotine metabolite ratio (NMR), an index of CYP2A6 activity, and genotyped/sequenced using deep amplicon exon sequencing, SNP array, genotype imputation and targeted capture sequencing. Amplicon exon sequencing was the gold standard to which other methods were compared within-individual for CYP2A6, CYP2A7, CYP2A13, and CYP2B6 exons to identify highly discordant positions. Linear regression models evaluated the association of CYP2A6*1B and rs8192733 genotypes (coded additively) with logNMR. All approaches were ≤2.6% discordant with the gold standard; discordant calls were concentrated at few positions. Fifteen positions were discordant in >10% of individuals, with 12 appearing in regions of high identity between homologous genes (e.g. CYP2A6 and CYP2A7). For six, allele frequencies in our study and online databases were discrepant, suggesting errors in online sources. In the European-ancestry group (n = 935), CYP2A6*1B and rs8192733 were associated with logNMR (P <0.001). A combined model found main effects of both variants on increasing logNMR. Similar trends were found in those of African ancestry (n = 506). Multiple genotyping/sequencing approaches used in this chromosome 19 region contain genotyping/sequencing errors, as do online databases. Gene-specific primers and SNP array probes must consider gene homology; short-read sequencing of related genes in a single reaction should be avoided. Using improved sequencing approaches, we characterized two gain-of-function 3'-UTR variants, including the relatively understudied rs8192733. [Abstract copyright: Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.]

KW - 3′-UTR

KW - CYP2A6

KW - nicotine metabolite ratio

KW - pharmacogenetics

KW - sequencing

KW - smoking

U2 - 10.1097/FPC.0000000000000466

DO - 10.1097/FPC.0000000000000466

M3 - Journal article

C2 - 35190513

VL - 32

SP - 159

EP - 172

JO - Pharmacogenetics and genomics

JF - Pharmacogenetics and genomics

SN - 1744-6880

IS - 4

ER -